Medicare Enrolled

Dr. Rajen Mehta, M.D.

Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
10496 KATY FWY STE 130, Houston, TX 77043
7134642928
In practice since 2006 (19 years)
NPI: 1457302879 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mehta

Dr. Rajen Mehta is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Mehta performed 4,076 Medicare services across 2,882 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mehta received a total of $6,630 from 29 pharmaceutical and/or device companies across 273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 23% volume in TX$ $6,630 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,076
Medicare services
Top 23% in TX for cardiovascular disease
2,882
Unique beneficiaries
$132
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~215 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,057$91$183
Electrocardiogram (EKG), 12-lead815$11$80
Regadenoson injection (Lexiscan) for heart stress test456$42$221
Hospital follow-up visit, moderate complexity276$63$276
Echocardiogram, transthoracic215$143$800
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician119$57$400
EKG interpretation and report118$7$60
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries113$424$540
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan111$1,940$7,309
Nuclear medicine study of heart muscle blood flow by pet110$147$487
New patient office visit (45-59 min)109$122$283
Initial hospital admission, moderate complexity102$99$360
Ultrasound of both sides of head and neck blood flow96$153$478
Remote pacemaker/defibrillator monitoring, 90 days78$18$60
Remote pacemaker monitoring, 90 days77$23$65
Office visit, established patient (20-29 min)50$56$122
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional33$21$67
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional33$676$1,846
Programming of dual lead pacemaker system28$27$112
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes24$10$132
Ultrasound study of arm or leg veins with compression and maneuvers21$148$495
Ultrasound of leg arteries or artery grafts20$179$850
Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional15$137$568
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.8% high complexity
22.9% medium
67.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,630
Total received (2018-2024)
Avg $947/year across 7 years
Top 42% in TX for cardiovascular disease
29
Companies
273
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,408 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$222 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$890
2023
$665
2022
$504
2021
$565
2020
$335
2019
$1,173
2018
$2,498

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$1,114
E.R. Squibb & Sons, L.L.C.
$875
Amgen Inc.
$587
Janssen Pharmaceuticals, Inc
$553
Novartis Pharmaceuticals Corporation
$495
Edwards Lifesciences Corporation
$362
BOSTON SCIENTIFIC CORPORATION
$305
Astellas Pharma US Inc
$260
ABIOMED
$250
Abbott Laboratories
$216
Boston Scientific Corporation
$195
Merck Sharp & Dohme LLC
$173
Impulse Dynamics (USA) Inc.
$163
Novo Nordisk Inc
$149
Biocompatibles, Inc.
$149
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$145
AstraZeneca Pharmaceuticals LP
$135
PFIZER INC.
$114
Medtronic, Inc.
$80
SANOFI-AVENTIS U.S. LLC
$66
BRACCO DIAGNOSTICS INC.
$38
BIOTRONIK INC.
$38
BARD PERIPHERAL VASCULAR, INC.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Regeneron Healthcare Solutions, Inc.
$29
Kiniksa Pharmaceuticals International, plc
$19
Kiniksa Pharmaceuticals, Ltd.
$17
Amarin Pharma Inc.
$17
Lexicon Pharmaceuticals, Inc.
$14
Top 3 companies account for 38.9% of total payments
Associated products mentioned in payments ›
AMPLATZER Vascular Plug and Accs · ASSURITY · Arcalyst · Assurity Pacemaker · BRILINTA · CAMZYOS · CHANTIX · Cardiogen-82 · ClosureFast · Corlanor · ELIQUIS · ENTRESTO · GENERAL ATHERECTOMY · HeartMate 3 Left Ventricular Assist Device · INVOKANA · Impella · JARDIANCE · JETSTREAM · LATITUDE Communicator Power Supply · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · Optimizer · Ozempic · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · SELECTSECURE · SYNERGY · VARITHENA · VENOVO · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $163 per 100 Medicare services performed
Looking for a cardiovascular disease in Houston?
Compare cardiovascular diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
376
Per 100K population
7.9
County median income
$73,104
Nearest hospital
HOUSTON BEHAVIORAL HEALTHCARE HOSPITAL LLC
3.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mehta is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 23% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mehta experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mehta performed 1,057 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $6,630 from 29 companies across 273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other cardiovascular diseases in Houston?
Dr. Mehta's average Medicare payment per service is $132. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →